SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-006279
Filing Date
2004-08-05
Accepted
2004-08-05 17:16:15
Documents
10
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c87101e10vq.htm 10-Q 220666
2 DEFERRED COMPENSATION PLAN c87101exv10w1.htm EX-10.1 27668
3 CHANGE IN CONTROL SEVERANCE PAY PLAN c87101exv10w2.htm EX-10.2 51907
4 2007 CHANGE IN CONTROL SEVERANCE PAY PLAN c87101exv10w3.htm EX-10.3 53729
5 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE c87101exv11.htm EX-11 11571
6 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS c87101exv12.htm EX-12 10592
7 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c87101exv31w1.htm EX-31.1 6341
8 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER c87101exv31w2.htm EX-31.2 6331
9 906 CERTIFICATION OF CEO AND CFO c87101exv32.htm EX-32 3731
10 CAUTIONARY STATEMENT c87101exv99w1.htm EX-99.1 8287
  Complete submission text file 0000950137-04-006279.txt   403631
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 04955489
SIC: 2834 Pharmaceutical Preparations